Cronos Group Inc (NASDAQ:CRON) was the target of some unusual options trading activity on Monday. Investors acquired 43,872 call options on the company. This is an increase of approximately 915% compared to the average daily volume of 4,324 call options.

Several institutional investors and hedge funds have recently made changes to their positions in CRON. ETF Managers Group LLC bought a new stake in shares of Cronos Group during the first quarter valued at approximately $13,583,000. JW Asset Management LLC bought a new stake in shares of Cronos Group during the first quarter valued at approximately $7,480,000. Lourd Capital LLC bought a new stake in shares of Cronos Group during the second quarter valued at approximately $379,000. Fiera Capital Corp bought a new stake in shares of Cronos Group during the first quarter valued at approximately $336,000. Finally, Commonwealth Equity Services LLC bought a new stake in shares of Cronos Group during the first quarter valued at approximately $294,000. 9.47% of the stock is owned by institutional investors.

Shares of CRON opened at $11.08 on Wednesday. The company has a market cap of $1.76 billion and a P/E ratio of 1,108.00. The company has a quick ratio of 44.71, a current ratio of 52.98 and a debt-to-equity ratio of 0.02. Cronos Group has a twelve month low of $1.50 and a twelve month high of $12.89.

Several brokerages recently weighed in on CRON. Canaccord Genuity downgraded shares of Cronos Group from a “hold” rating to a “sell” rating in a research report on Tuesday, May 1st. Beacon Securities reissued a “buy” rating on shares of Cronos Group in a research report on Friday, May 4th.

Cronos Group Company Profile

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada.

Featured Story: Technical Analysis of Stocks, How Can It Help

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.